GSK Eyes FDA Filing After Immunotherapy Succeeds in Key Rectal Cancer Study
GSK has results from a pivotal clinical trial showing rectal cancer patients treated with its drug avoided the…
Surgery-Free Rectal Cancer Treatment Edges Closer as Dostarlimab Clears Registrational Trial
GSK announced Sunday that dostarlimab (Jemperli), its PD-1–blocking immunotherapy, met the primary endpoint of the AZUR-1 registrational Phase…
GSK reports Jemperli rectal cancer trial results
GSK reported positive interim results from the AZUR-1 Phase II trial of Jemperli in dMMR/MSI-H locally advanced rectal…
GSK’s Jemperli meets main goal in mid-stage rectal cancer trial
GSK said on Monday its cancer drug Jemperli met the primary goal of a mid-stage trial, with a…
Immunai’s digital ‘plumbing’ keeps AstraZeneca coming back
[Adobe Stock] Immunai, a startup building a foundation model of the human immune system, has expanded its oncology…